TY - JOUR
T1 - Transdermal immunization using solid-in-oil nanodispersion with CpG oligodeoxynucleotide adjuvants
AU - Kitaoka, Momoko
AU - Naritomi, Ayaka
AU - Hirakawa, Yuya
AU - Kamiya, Noriho
AU - Goto, Masahiro
N1 - Funding Information:
This work was financed by a Grant-in-Aid for Scientific Research (S) 24226019 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. G.). We thank Professor Yoshiki Katayama for animal experiments.
Publisher Copyright:
© 2014 Springer Science+Business Media New York.
PY - 2015/4
Y1 - 2015/4
N2 - Purpose: Simple and noninvasive vaccine administration alternatives to injections are desired. A solid-in-oil (S/O) nanodispersion system was able to overcome skin barriers and induce an immune response; however, antibody levels remained low. We applied an immune potentiator, CpG oligodeoxynucleotide (ODN), to enhance the immune response by controlling the T helper 1 (Th1)/T helper 2 (Th2) balance. Methods: S/O nanodispersions containing ovalbumin (OVA) and CpG ODN (CpG-A or CpG-B) were characterized by size distribution analysis and a protein release test. The skin permeation of fluorescence-labeled OVA was observed by fluorescence microscopy. Antigen-specific IgG, IgG1, and IgG2a responses were measured by enzyme-linked immunosorbent assay. Results: Co-encapsulation of CpG ODNs in S/O nanodispersions enhanced induction of OVA-specific IgG. S/O nanodispersion containing OVA and CpG-A had a smaller mean particle size and permeated the skin more efficiently. In contrast, CpG-B showed the highest protein release and induction of OVA-specific IgG. IgG subclass analysis revealed that OVA induced a Th2-dominant immune response, while the S/O nanodispersion containing CpG-A skewed the immune response toward a Th1-bias. Conclusions: In combination with CpG ODN, the S/O nanodispersion system efficiently induced an antigen-specific antibody response. The Th1/Th2 immune balance could be controlled by the selection of CpG ODN type.
AB - Purpose: Simple and noninvasive vaccine administration alternatives to injections are desired. A solid-in-oil (S/O) nanodispersion system was able to overcome skin barriers and induce an immune response; however, antibody levels remained low. We applied an immune potentiator, CpG oligodeoxynucleotide (ODN), to enhance the immune response by controlling the T helper 1 (Th1)/T helper 2 (Th2) balance. Methods: S/O nanodispersions containing ovalbumin (OVA) and CpG ODN (CpG-A or CpG-B) were characterized by size distribution analysis and a protein release test. The skin permeation of fluorescence-labeled OVA was observed by fluorescence microscopy. Antigen-specific IgG, IgG1, and IgG2a responses were measured by enzyme-linked immunosorbent assay. Results: Co-encapsulation of CpG ODNs in S/O nanodispersions enhanced induction of OVA-specific IgG. S/O nanodispersion containing OVA and CpG-A had a smaller mean particle size and permeated the skin more efficiently. In contrast, CpG-B showed the highest protein release and induction of OVA-specific IgG. IgG subclass analysis revealed that OVA induced a Th2-dominant immune response, while the S/O nanodispersion containing CpG-A skewed the immune response toward a Th1-bias. Conclusions: In combination with CpG ODN, the S/O nanodispersion system efficiently induced an antigen-specific antibody response. The Th1/Th2 immune balance could be controlled by the selection of CpG ODN type.
UR - http://www.scopus.com/inward/record.url?scp=84925484586&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925484586&partnerID=8YFLogxK
U2 - 10.1007/s11095-014-1554-5
DO - 10.1007/s11095-014-1554-5
M3 - Article
C2 - 25361868
AN - SCOPUS:84925484586
SN - 0724-8741
VL - 32
SP - 1486
EP - 1492
JO - Pharmaceutical Research
JF - Pharmaceutical Research
IS - 4
ER -
